Evidence map›Paper›PMID 38923267›Full record

Trial reportJournal of cosmetic dermatology2024

Dezocine as preemptive analgesia alleviates ultrapulse CO

Qian Zhang, Xiaoqin Li, Yuanli Wang, Ni Gao, Rongli Zhang, Jingjing Wu, Fengqin Wu, Pu Song, Min Chen, Gang Wang and 1 more

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Journal of cosmetic dermatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Calcium Hydroxylapatite Combined with COAesthetic plastic surgery · 2026
    Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Qian ZhangDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
Xiaoqin LiDepartment of Anesthesiology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
Yuanli WangDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
Ni GaoDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
Rongli ZhangDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
Jingjing WuDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
Fengqin WuDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
Pu SongDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
Min ChenDepartment of Anesthesiology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
Gang WangDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
Lin GaoDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.

Funding

the National Natural Science Foundation of China 82173436the National Natural Science Foundation of China 82373499
6 · The paper itself

Abstract

backgroundUltrapluse CO

methodsThe study cohort included 78 outpatients with acne scars between February and April 2023. Patients were randomly assigned into three groups with intravenous injection (iv) of DZC prior to laser treatment: (1) control, iv of saline; (2) DZC group 1 (DZC_1), iv of DZC at 0.15 mg/kg; and (3) DZC_2, iv of DZC at 0.20 mg/kg. After 30 min, one session of ultrapulse CO

resultsOperative success rates for patients in the control, DZC_1, and DZC_2 groups were 34.6%, 84.6%, and 100%, respectively. DZC administered with either dosage significantly reduced the VAS and AVAT scores of patients in treatment groups as compared with the subjects in the control group during the course of ultrapulse CO

conclusionsDZC as preemptive analgesia could effectively reduce pain and anxiety induced by ultrapulse CO

Indexed as

Acne VulgarisCicatrixLasers, GasPain MeasurementTetrahydronaphthalenesAdultAnalgesiaBridged Bicyclo Compounds, HeterocyclicFemaleHumansMaleProcedural PainTreatment OutcomeYoung AdultBridged Bicyclo Compounds, HeterocyclicdezocineTetrahydronaphthalenesacne scarsdezocinereduction of painultrapluse CO2 fractional laser

Identifiers

PMID38923267
PMCPMC13649093

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.